FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

33609111000001105: Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
182261000001117 Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
182271000001110 Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Is a Product containing precisely naratriptan (as naratriptan hydrochloride) 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has active ingredient Naratriptan hydrochloride false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has specific active ingredient Naratriptan hydrochloride true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Has basis of strength substance Naratriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) 6 tablet Has AMP True Naratriptan 2.5mg tablets (Healthcare Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start